The Role of Blood Flow Restriction Therapy in Postop Rehabilitation of Foot and Ankle Injuries

December 4, 2024 updated by: Michael Johnson, University of Alabama at Birmingham
The purpose of the study is to determine the role of blood flow restriction (BFR) + neuromuscular electrical stimulation (NMES) in improving post-operative physical therapy and recovery after ankle fracture surgery. We expect to see improved muscle strength, less muscle wasting, and improved functional recovery after surgery when making these additions to routine post-operative (postop) physical therapy protocols.

Study Overview

Detailed Description

Few studies have examined BFR in patients sustaining operative foot and ankle injuries. Due to the weight bearing limitations and prolonged immobilization following these injuries, patients often experience increased time away from work and delays with return to sport. These factors are responsible for the rapid muscle atrophy that occurs in the immediate post injury period because of immobility and disuse. Recently, blood flow restriction (BFR) therapy has been shown to be effective in improving muscle strength and preventing atrophy when combined with low load resistance training physical therapy programs.7,8 Neuromuscular electrical stimulation (NMES) is an adjunctive agent that has been show to augment the effects of BFR alone.4 The null hypothesis is that a 2 week BFR + NMES + low load resistance training program in patients age >= 18 recovering from foot and ankle surgery will have no effect on short term (2 weeks postop) lower extremity muscle hypertrophy or atrophy, patient pain and satisfaction, or functional recovery after foot and ankle surgery.

Study Type

Interventional

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alabama
      • Birmingham, Alabama, United States, 35243
        • University of Alabama at Birmingham

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • isolated, closed low-energy rotational ankle fracture without prior surgery or implants to injured area

Exclusion Criteria:

  • history of Deep Vein Thrombosis in affected extremity
  • history of significant cardiac disease defined as a recent stent placement in past
  • history of peripheral arterial disease
  • history of sickle cell disease
  • history of coagulopathy
  • presenting to surgery >14 days after injury

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Group
receiving physical therapy with BFR+NMES devices used at sub-therapeutic levels
This means that the BFR tourniquet and the NMES device will be at such low settings as to not create the treatment effect but subject will have the equipments on their thigh during exercise
Experimental: Treatment Group
receiving physical therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic
This group will receive therapy with BFR+NMES devices used at settings that are deemed by prior studies to be therapeutic.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess for calf muscle atrophy as measured by calf circumference
Time Frame: 2 weeks postop
Calf circumference will be measured using a measuring tape
2 weeks postop
Assess for calf muscle atrophy as measured by hand held dynamometry
Time Frame: 2 weeks postop
Hand held Dynamometry will be used to measure the length-tension relationship of the muscle in pounds
2 weeks postop

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient tolerance of the BFR treatment using the Visual Analogue Pain Scale.
Time Frame: 2 weeks postop

The Visual Analogue Pain Scale is used during the beginning, midpoint, and end of a session.

This scale ranges from 0-10 which 0 being "no pain" and 10 being "worst pain"

2 weeks postop
Patient tolerance of the BFR treatment using the the Borg Rating of Perceived Exertion f
Time Frame: 2 weeks postop

The Borg Rating of Perceived Exertion will be used for each session and exercise.

This rating ranges from 6-20 with 6 being no exertion at all, and 20 being maximum effort

2 weeks postop

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

August 1, 2028

Study Completion (Estimated)

December 1, 2029

Study Registration Dates

First Submitted

March 2, 2023

First Submitted That Met QC Criteria

May 3, 2023

First Posted (Actual)

May 6, 2023

Study Record Updates

Last Update Posted (Estimated)

December 9, 2024

Last Update Submitted That Met QC Criteria

December 4, 2024

Last Verified

December 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRB-300009735

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fracture of Foot

Clinical Trials on BFR+NMES at sub therapeutic level

Subscribe